Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VISMODEGIB vs VITAMIN D NOS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VISMODEGIB vs VITAMIN D NOS: Safety Overview

Metric VISMODEGIB VITAMIN D NOS
Total FAERS Reports 8,135 2,567
Deaths Reported 864 269
Death Rate 10.6% 10.5%
Hospitalizations 974 1,029
Average Patient Age 69.6 yrs 55.6 yrs
% Female Patients 39.3% 69.9%
FDA Approval Date Jan 30, 2012 N/A
Manufacturer Genentech, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A